Related references
Note: Only part of the references are listed.Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease
Simon R. W. Stott et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2014)
Six Weeks of Voluntary Exercise don't Protect C57BL/6 Mice Against Neurotoxicity of MPTP and MPP+
Aderbal S. Aguiar et al.
NEUROTOXICITY RESEARCH (2014)
Evaluation of Nigrostriatal Neurodegeneration and Neuroinflammation Following Repeated Intranasal 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice, an Experimental Model of Parkinson's Disease
Fabrine S. M. Tristao et al.
NEUROTOXICITY RESEARCH (2014)
MALDI Mass Spectrometry Imaging of 1-Methyl-4-phenylpyridinium (MPP+) in Mouse Brain
Hanane Kadar et al.
NEUROTOXICITY RESEARCH (2014)
Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
Cristina Limatola et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model
Marcio Lazzarini et al.
GLIA (2013)
DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson's disease
Kiyoka Kinugawa et al.
JOURNAL OF NEUROINFLAMMATION (2013)
MPTP-Induced Dopamine Neuron Degeneration and Glia Activation Is Potentiated in MDMA-Pretreated Mice
Giulia Costa et al.
MOVEMENT DISORDERS (2013)
Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin
Wei Shao et al.
NATURE (2013)
Parkin-Knockout Mice did not Display Increased Vulnerability to Intranasal Administration of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Aderbal S. Aguiar et al.
NEUROTOXICITY RESEARCH (2013)
Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
Carmen Noelker et al.
SCIENTIFIC REPORTS (2013)
Classic and New Animal Models of Parkinson's Disease
Javier Blesa et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
The Soluble Isoform of CX3CL1 Is Necessary for Neuroprotection in a Mouse Model of Parkinson's Disease
Josh M. Morganti et al.
JOURNAL OF NEUROSCIENCE (2012)
Intranasal Administration of Neurotoxicants in Animals: Support for the Olfactory Vector Hypothesis of Parkinson's Disease
Rui D. S. Prediger et al.
NEUROTOXICITY RESEARCH (2012)
Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system
Ma Carmen Hernandez-Romero et al.
NEUROTOXICOLOGY (2012)
In Vivo Manganese Exposure Modulates Erk, Akt and Darpp-32 in the Striatum of Developing Rats, and Impairs Their Motor Function
Fabiano M. Cordova et al.
PLOS ONE (2012)
Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson's disease
Rui D. S. Prediger et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease
Mibel M. Pabon et al.
JOURNAL OF NEUROINFLAMMATION (2011)
NEW evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease
Sun Shan et al.
NEUROBIOLOGY OF AGING (2011)
Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats
An-Li Wang et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge
Angela M. Wynne et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Altered expression of neuronal nitric oxide synthase in weaver mutant mice
Roberta Cavalcanti-Kwiatkoski et al.
BRAIN RESEARCH (2010)
Neuroglia in neurodegeneration
Michael T. Heneka et al.
BRAIN RESEARCH REVIEWS (2010)
Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide
Angela W. Corona et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease
Martin Fuhrmann et al.
NATURE NEUROSCIENCE (2010)
Astrocytes and Therapeutics for Parkinson's Disease
Phillip M. Rappold et al.
NEUROTHERAPEUTICS (2010)
Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson's Disease
Rui D. S. Prediger et al.
NEUROTOXICITY RESEARCH (2010)
Brain APCs including microglia are only differential and positional polymorphs
Anirban Ghosh
ANNALS OF NEUROSCIENCES (2010)
MPTP Lesion Causes Neuroinflammation and Deficits in Object Recognition in Wistar Rats
Wen-Fu Wang et al.
BEHAVIORAL NEUROSCIENCE (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling
David M. Thomas et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Glial Cells as Players in Parkinsonism: The Good, the Bad, and the Mysterious Glia
Maria A. Mena et al.
NEUROSCIENTIST (2008)
Epidemiologic studies of environmental exposures in Parkinson's disease
Alexis Elbaz et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease
Rui D. S. Prediger et al.
EXPERIMENTAL NEUROLOGY (2006)
Somatotopically arranged inputs from putamen and subthalamic nucleus to primary motor cortex
Shigehiro Miyachi et al.
NEUROSCIENCE RESEARCH (2006)
Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice
Ana I. Rojo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease
Yoon Seong Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Diagnosis and treatment of Parkinson disease: molecules to medicine
Joseph M. Savitt et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Control of microglial neurotoxicity by the fractalkine receptor
Astrid E. Cardona et al.
NATURE NEUROSCIENCE (2006)
Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease
Rattanavijit Vijitruth et al.
JOURNAL OF NEUROINFLAMMATION (2006)
Pharmacological validation of a mouse model of L-DOPA-induced dyskinesia
N Lundblad et al.
EXPERIMENTAL NEUROLOGY (2005)
Nasal drug administration: Potential for targeted central nervous system delivery
CL Graff et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
ATP mediates rapid microglial response to local brain injury in vivo
D Davalos et al.
NATURE NEUROSCIENCE (2005)
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
A Nimmerjahn et al.
SCIENCE (2005)
The dopamine transporter: role in neurotoxicity and human disease
MJ Bannon
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Differential activation of astrocytes by innate and adaptive immune stimuli
PA Carpentier et al.
GLIA (2005)
CX(3)CL1 (fractalkine) and CX(3)CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin
Dan Sunnemark et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment
S Sugama et al.
NEUROSCIENCE (2004)
Adenosine Prevents the Death of Mesencephalic Dopaminergic Neurons by a Mechanism that Involves Astrocytes
Patrick P. Michel et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/glial mesencephalic cultures requires the repression of presumptive astrocytes
S Mourlevat et al.
MOLECULAR PHARMACOLOGY (2003)
Nitric oxide and reactive oxygen species in Parkinson's disease
K Tieu et al.
IUBMB LIFE (2003)
Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia
R Cotter et al.
JOURNAL OF NEUROVIROLOGY (2002)
Fractalkine and fractalkine receptors in human neurons and glial cells
K Hatori et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging
F Cicchetti et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
α-Synuclein and the Lewy body disorders
DW Dickson
CURRENT OPINION IN NEUROLOGY (2001)
Alpha-synuclein and neurodegenerative diseases
M Goedert
NATURE REVIEWS NEUROSCIENCE (2001)
Generation and analysis of mice lacking the chemokine fractalkine
DN Cook et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Functional changes of the basal ganglia circuitry in Parkinson's disease
F Blandini et al.
PROGRESS IN NEUROBIOLOGY (2000)
Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival
O Meucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion
S Jung et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
